Sunday, June 14, 2026
🇺🇸 FDA

Patent directory · USPTO A61K / A61P

Browse patents

Browse 30,257 pharma-relevant patents (US A61K/A61P) linked to tracked companies, drugs, and pipeline programs.

Patents indexed 30,257
Companies 1,769
Drugs linked 4,797

Quick answer

NovaPharmaNews indexes 30,257 US pharmaceutical patents from USPTO PatentsView (CPC A61K/A61P), cross-linked to company assignees, drug INN profiles, and pipeline programs. Search by patent number, applicant, title, or CPC code — or use facet hubs for expiring patents, assignees, and therapeutic areas.

Patent results

Page 986 of 1,261

  1. US 7807164

    Lyophilized VEGF antagonist formulations for intravitreal administration

    REGENERON PHARMACEUTICALS, INC. · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  2. US 7807168

    Selection of human TNFα specific antibodies

    VACCINEX, INC. · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  3. US 7807383

    Diagnosing and treating hormone resistant cancers

    The Board of Regents of the University of Texas System · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  4. US 7807346

    High-throughput assay for virus entry and drug screening

    The Board of Regents of the University of Texas System · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  5. US 7807179

    Modified reoviral therapy

    The Board of Regents of the University of Texas System · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  6. US 7807393

    Biomarkers for prostate cancer

    Northwestern University · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  7. US 7807174

    Class of therapeutic protein based molecules

    United States of America/NIH · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  8. US 7807458

    Multilineage-inducible cells and uses thereof

    THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE DEPARTMENT OF VETERANS AFFAIRS · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  9. US 7807805

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  10. US 7807644

    Chimeric proteins with phosphatidylserine binding domains

    The Board of Regents of the University of Oklahoma · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  11. US 7807659

    Caspase inhibitors and uses thereof

    Vertex Pharmaceuticals Incorporated · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  12. US 7807623

    Use of pentagastrin to inhibit gastric acid secretion or as a diuretic

    The Regents of the University of California · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  13. US 7807619

    Compositions and methods for modification of biomolecules

    The Regents of the University of California · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  14. US 7807618

    Methods and compositions for delivering enzymes and nucleic acid molecules to brain, bone and other tissues

    The Board of Regents of the University of Texas System · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  15. US 7807787

    NELL-1 peptide

    The Regents of the University of California · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  16. US 7807781

    Inhibitors of serine protease activity and their use in methods and compositions for treatment of viral infections

    The Regents of the University of Colorado · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  17. US 7807651

    Methods and materials for pain management

    The Board of Regents of the University of Texas System · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  18. US 7807689

    Dipeptidyl peptidase inhibitors

    Takeda Pharmaceutical Company Limited · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  19. US 7807645

    Method of treating degenerative disorders of the nervous system by administration of fibrinogen fragment

    The Regents of the University of California · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  20. US 7807640

    Orally administered peptides synergize statin activity

    The Regents of the University of California · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  21. US 7807463

    Pre-transplant accommodated organs resistant to anti-donor immunity

    BOARD OF REGENTS OF THE UNIVERSITY OF NEBRASKA · Granted Oct 5, 2010 · Expires Sep 30, 2030

    granted

  22. US 2010247626

    PEGYLATED COMPOUNDS FOR AGE-RELATED MACULAR DEGENERATION

    ALBRECHT VOLKER [DE] · Granted Sep 30, 2010 · Expires Sep 25, 2030

    granted

  23. US 7803939

    2,4-pyrimidinediamine compounds and their uses

    Rigel Pharmaceuticals, Inc. · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted

  24. US 7803614

    Melanoma antigens and their use in diagnostic and therapeutic methods

    The United States of America, as represented by the Department of Health and Human Services · Granted Sep 28, 2010 · Expires Sep 23, 2030

    granted

Frequently asked questions

What patents are included in this directory?

We index 30,257 published US pharma-relevant patents filtered to CPC classes A61K and A61P, with assignee links to our company directory where a match exists.

How do I search for a patent?

Use the search box to match patent number, title, applicant name, or CPC classification (e.g. A61K). For cross-entity queries spanning news and drugs, use the global search.

How is this different from the patent intelligence dashboard?

The dashboard at /patents highlights expirations, recent grants, and assignee rankings. Browse is the full paginated directory with search — best for looking up a specific filing or applicant portfolio slice.

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.